Cargando…
Corrigendum to “Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E(2) Receptor EP4 Pathway”
Autores principales: | Hong, Yu Ah, Yang, Keum Jin, Jung, So Young, Park, Ki Cheol, Choi, Hyunsu, Oh, Jeong Min, Lee, Sang Ju, Chang, Yoon Kyung, WheePark, Cheol, Yang, Chul Woo, Kim, Suk Young, Hwang, Hyeon Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572087/ https://www.ncbi.nlm.nih.gov/pubmed/28883900 http://dx.doi.org/10.1155/2017/1913954 |
Ejemplares similares
-
Paricalcitol Pretreatment Attenuates Renal Ischemia-Reperfusion Injury via Prostaglandin E(2) Receptor EP4 Pathway
por: Hong, Yu Ah, et al.
Publicado: (2017) -
Paricalcitol attenuates lipopolysaccharide-induced inflammation and apoptosis in proximal tubular cells through the prostaglandin E(2) receptor EP4
por: Hong, Yu Ah, et al.
Publicado: (2017) -
Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation
por: Hong, Yu Ah, et al.
Publicado: (2020) -
Corrigendum to “Protective Effects of Pretreatment with Oleanolic Acid in Rats in the Acute Phase of Hepatic Ischemia-Reperfusion Injury: Role of the PI3K/Akt Pathway”
por: Gui, Bo, et al.
Publicado: (2020) -
Laminarin Pretreatment Provides Neuroprotection against Forebrain Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Neuroinflammation in Aged Gerbils
por: Park, Joon Ha, et al.
Publicado: (2020)